Evidence map›Paper›PMID 25702873›Full record

ArticleMolecular cell2015

Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death.

Gabriel Ichim, Jonathan Lopez, Shafiq U Ahmed, Nathiya Muthalagu, Evangelos Giampazolias, M Eugenia Delgado, Martina Haller, Joel S Riley, Susan M Mason, Dimitris Athineos and 10 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 294 papers.

0numbers the graph read from it
0cells of the map it votes in
294citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

294 citing papers in PubMed, 451 citations in OpenAlex.

  1. Article
  2. Anastasis: an unwelcome guest in cancer therapy.Apoptosis : an international journal on programmed cell death · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Autoinflammatory syndromes of STING and TREX1 dysfunction.The Journal of clinical investigation · 2026
    Review
  17. Review
  18. Article
  19. Article
  20. Article

234 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 4 countries.

Gabriel IchimCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Jonathan LopezCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Shafiq U AhmedInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Nathiya MuthalaguCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Evangelos GiampazoliasCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
M Eugenia DelgadoCentre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin 2, Ireland, Baylor College of Medicine, Houston, TX 77030, USA.
Martina HallerCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Joel S RileyCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Susan M MasonCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Dimitris AthineosCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Melissa J ParsonsCenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pediatrics-Hematology, Baylor College of Medicine, Houston, TX 77030, USA.
Bert van de KooijDivision of Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.
Lisa Bouchier-HayesCenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pediatrics-Hematology, Baylor College of Medicine, Houston, TX 77030, USA.
Anthony J ChalmersInstitute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Rogier W RooswinkelDivision of Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.
Andrew OberstDepartment of Immunology, University of Washington, 750 Republican Street, Seattle, WA 98109, USA.
Karen BlythCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Markus RehmCentre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin 2, Ireland, Baylor College of Medicine, Houston, TX 77030, USA.
Daniel J MurphyCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Stephen W G TaitCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK. Electronic address: stephen.tait@glasgow.ac.uk.
Cancer Research UK Scotland Institute · GBUniversity of Glasgow · GBBaylor College of Medicine · USRoyal College of Surgeons in Ireland · IEThe Netherlands Cancer Institute · NLCancer Research UK · GBUniversity of Washington · US

Funding

The physiological role of RIPK3-dependent necroptosisR01AI108685 · NIAID · UNIVERSITY OF WASHINGTON · PI OBERST, ANDREW ATWELL · 2014 to 2018
$2.5M
Biotechnology and Biological Sciences Research Council BB/K008374/1Cancer Research UKMedical Research Council G0802755NIAID NIH HHS R01 AI108685
6 · The paper itself

Abstract

During apoptosis, the mitochondrial outer membrane is permeabilized, leading to the release of cytochrome c that activates downstream caspases. Mitochondrial outer membrane permeabilization (MOMP) has historically been thought to occur synchronously and completely throughout a cell, leading to rapid caspase activation and apoptosis. Using a new imaging approach, we demonstrate that MOMP is not an all-or-nothing event. Rather, we find that a minority of mitochondria can undergo MOMP in a stress-regulated manner, a phenomenon we term "minority MOMP." Crucially, minority MOMP leads to limited caspase activation, which is insufficient to trigger cell death. Instead, this caspase activity leads to DNA damage that, in turn, promotes genomic instability, cellular transformation, and tumorigenesis. Our data demonstrate that, in contrast to its well-established tumor suppressor function, apoptosis also has oncogenic potential that is regulated by the extent of MOMP. These findings have important implications for oncogenesis following either physiological or therapeutic engagement of apoptosis.

Indexed as

DNA DamageGenomic InstabilityAnimalsApoptosisBiphenyl CompoundsBlotting, WesternCaspasesCell Line, TumorCyclin-Dependent Kinase Inhibitor p19Dose-Response Relationship, DrugEmbryo, MammalianFibroblastsHCT116 CellsHeLa CellsHistonesHumansABT-737Biphenyl CompoundsCaspasesCdkn2d protein, mouseCyclin-Dependent Kinase Inhibitor p19H2AX protein, humanHistonesNitrophenolsPiperazinesProto-Oncogene Proteins c-bcl-2StaurosporineSulfonamides

Identifiers

PMID25702873
PMCPMC4352766
OpenAlexW2099583458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.